Annual Book Value
-$24.23 M
-$11.12 M-84.84%
December 31, 2022
Summary
- As of February 22, 2025, ARDS annual book value is -$24.23 million, with the most recent change of -$11.12 million (-84.84%) on December 31, 2022.
- During the last 3 years, ARDS annual book value has fallen by -$27.87 million (-766.45%).
- ARDS annual book value is now -192.09% below its all-time high of $26.31 million, reached on December 31, 2018.
Performance
ARDS Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
-$11.80 M
+$3.11 M+20.87%
September 30, 2023
Summary
- As of February 22, 2025, ARDS quarterly book value is -$11.80 million, with the most recent change of +$3.11 million (+20.87%) on September 30, 2023.
- Over the past year, ARDS quarterly book value has increased by +$3.11 million (+20.87%).
- ARDS quarterly book value is now -137.62% below its all-time high of $31.37 million, reached on September 30, 2018.
Performance
ARDS Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
ARDS Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -84.8% | +20.9% |
| 3 y3 years | -766.5% | -4.5% |
| 5 y5 years | +61.4% | -234.5% |
ARDS Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -84.8% | at low | at high | +67.0% |
| 5 y | 5-year | -766.5% | at low | -424.6% | +67.0% |
| alltime | all time | -192.1% | +61.4% | -137.6% | +83.6% |
Aridis Pharmaceuticals Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$11.80 M(-20.9%) |
| Jun 2023 | - | -$14.91 M(-46.5%) |
| Mar 2023 | - | -$27.88 M(+15.1%) |
| Dec 2022 | -$24.23 M(+84.8%) | -$24.23 M(-32.4%) |
| Sep 2022 | - | -$35.82 M(+28.2%) |
| Jun 2022 | - | -$27.93 M(+36.9%) |
| Mar 2022 | - | -$20.41 M(+55.7%) |
| Dec 2021 | -$13.11 M(+51.0%) | -$13.11 M(+215.5%) |
| Sep 2021 | - | -$4.16 M(-69.2%) |
| Jun 2021 | - | -$13.49 M(+57.7%) |
| Mar 2021 | - | -$8.55 M(-1.5%) |
| Dec 2020 | -$8.68 M | -$8.68 M(-23.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -$11.30 M(+86.0%) |
| Jun 2020 | - | -$6.07 M(+155.5%) |
| Mar 2020 | - | -$2.38 M(-165.4%) |
| Dec 2019 | $3.64 M(-86.2%) | $3.64 M(-58.6%) |
| Sep 2019 | - | $8.78 M(-19.2%) |
| Jun 2019 | - | $10.86 M(-41.9%) |
| Mar 2019 | - | $18.71 M(-28.9%) |
| Dec 2018 | $26.31 M(-141.9%) | $26.31 M(-16.1%) |
| Sep 2018 | - | $31.37 M(-143.6%) |
| Jun 2018 | - | -$72.02 M(+2.3%) |
| Mar 2018 | - | -$70.41 M(+12.2%) |
| Dec 2017 | -$62.77 M(+39.1%) | -$62.77 M |
| Dec 2016 | -$45.12 M | - |
FAQ
- What is Aridis Pharmaceuticals annual book value?
- What is the all time high annual book value for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals annual book value year-on-year change?
- What is Aridis Pharmaceuticals quarterly book value?
- What is the all time high quarterly book value for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals quarterly book value year-on-year change?
What is Aridis Pharmaceuticals annual book value?
The current annual book value of ARDS is -$24.23 M
What is the all time high annual book value for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high annual book value is $26.31 M
What is Aridis Pharmaceuticals annual book value year-on-year change?
Over the past year, ARDS annual book value has changed by -$11.12 M (-84.84%)
What is Aridis Pharmaceuticals quarterly book value?
The current quarterly book value of ARDS is -$11.80 M
What is the all time high quarterly book value for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high quarterly book value is $31.37 M
What is Aridis Pharmaceuticals quarterly book value year-on-year change?
Over the past year, ARDS quarterly book value has changed by +$3.11 M (+20.87%)